These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31258768)

  • 1. Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging.
    Chon HS; Sehovic M; Marchion D; Walko C; Xiong Y; Extermann M
    J Cancer; 2019; 10(12):2604-2618. PubMed ID: 31258768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
    Lawal AO; Musekiwa A; Grobler L
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
    Han GH; Yun H; Chung JY; Kim JH; Cho H
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
    Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
    [No Abstract]   [Full Text] [Related]  

  • 7. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
    Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
    Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression.
    Li X; Ding W; Rao Y; Qu P
    J Ovarian Res; 2023 Jul; 16(1):131. PubMed ID: 37403117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
    Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
    J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer.
    Zhang J; Tang L; Shen L; Zhou S; Duan Z; Xiao L; Cao Y; Mu X; Zha L; Wang H
    Gynecol Oncol; 2012 Oct; 127(1):223-30. PubMed ID: 22721732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.
    Natoli M; Gallon J; Lu H; Amgheib A; Pinato DJ; Mauri FA; Marafioti T; Akarca AU; Ullmo I; Ip J; Aboagye EO; Brown R; Karadimitris A; Ghaem-Maghami S
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33436485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients.
    Chen L; Yao Y; Sun L; Zhou J; Liu J; Wang J; Li J; Tang J
    J Ovarian Res; 2015 Nov; 8():78. PubMed ID: 26589590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
    Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
    J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
    Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
    BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell.
    Zhou W; Ma J; Zhao H; Wang Q; Guo X; Chen L; Cao Z; Xu J; Zhang B; Zhou X
    Mol Cell Proteomics; 2023 Apr; 22(4):100520. PubMed ID: 36842607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database.
    Xu J; Hussain I; Wang L; Deng K; Zhao L; Zhou K; Zhang L; Xu Z; Li K
    Arch Gynecol Obstet; 2021 Oct; 304(4):1007-1020. PubMed ID: 33635405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.
    Deng Y; Liu L; Feng W; Lin Z; Ning Y; Luo X
    Recent Pat Anticancer Drug Discov; 2021; 16(4):533-539. PubMed ID: 34551701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
    Shuang T; Wang M; Zhou Y; Shi C
    Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.